---
title: "Nuwellis, Inc. (NUWE.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NUWE.US.md"
symbol: "NUWE.US"
name: "Nuwellis, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-22T02:23:30.036Z"
locales:
  - [en](https://longbridge.com/en/quote/NUWE.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NUWE.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NUWE.US.md)
---

# Nuwellis, Inc. (NUWE.US)

## Company Overview

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.nuwellis.com](https://www.nuwellis.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.57)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 116 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.20% |  |
| Net Profit YoY | -91.31% |  |
| P/B Ratio | 0.91 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2607779.39 |  |
| Revenue | 8769000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -584.73% | E |
| Profit Margin | -214.90% | E |
| Gross Margin | 70.08% | A |
| Revenue YoY | -0.20% | D |
| Net Profit YoY | -91.31% | E |
| Total Assets YoY | 2.28% | C |
| Net Assets YoY | -19.77% | E |
| Cash Flow Margin | 60.44% | C |
| OCF YoY | -0.20% | D |
| Turnover | 1.24 | A |
| Gearing Ratio | 59.89% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Nuwellis, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.20%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-91.31%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.91",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2607779.39",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "8769000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-584.73%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-214.90%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "70.08%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-0.20%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-91.31%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.28%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-19.77%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "60.44%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-0.20%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "1.24",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "59.89%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.14 | 57/183 | - | - | - |
| PB | 0.92 | 24/183 | 1.09 | 0.90 | 0.39 |
| PS (TTM) | 0.30 | 7/183 | 0.45 | 0.37 | 0.26 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.00 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NUWE.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NUWE.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NUWE.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NUWE.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**